clonidine has been researched along with Multiple System Atrophy Syndrome in 14 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was aimed at comparing the diagnostic accuracy of the growth hormone (GH) response to clonidine, arginine and both combined in order to establish a more reliable test to differentiate parkinsonism type multiple system atrophy (MSA-p) from Parkinson's disease (PD)." | 9.14 | The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathic Parkinson's disease. ( Fu, Y; Song, C; Wan, Q; Zeng, Y; Zhang, K, 2010) |
| "We assessed the effects of clonidine on blood pressure (BP) and heart rate (HR) in multiple system atrophy (MSA), where the autonomic nervous system lesion site is preganglionic, and in pure autonomic failure (PAF), where it is postganglionic." | 9.12 | Hemodynamic effects of clonidine in two contrasting models of autonomic failure: multiple system atrophy and pure autonomic failure. ( Asahina, M; Mathias, CJ; Watson, L; Young, TM, 2006) |
| "The clonidine-growth hormone test (CGHT) has been proposed as a means of differentiating multiple system atrophy (MSA) from idiopathic Parkinson's disease (PD)." | 7.71 | Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography. ( Kim, BJ; Lee, EA; Lee, WY, 2002) |
| "Clonidine, a centrally active alpha 2-adrenoreceptor agonist used to lower blood pressure, has been proposed to differentiate central from peripheral autonomic deficits and multiple system atrophy (MSA) from untreated idiopathic Parkinson's disease (IPD)." | 7.70 | Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease? ( Echaniz-Laguna, A; Guiraud-Chaumeil, C; Tranchant, C; Warter, JM, 2000) |
| "This study was aimed at comparing the diagnostic accuracy of the growth hormone (GH) response to clonidine, arginine and both combined in order to establish a more reliable test to differentiate parkinsonism type multiple system atrophy (MSA-p) from Parkinson's disease (PD)." | 5.14 | The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathic Parkinson's disease. ( Fu, Y; Song, C; Wan, Q; Zeng, Y; Zhang, K, 2010) |
| "We assessed the effects of clonidine on blood pressure (BP) and heart rate (HR) in multiple system atrophy (MSA), where the autonomic nervous system lesion site is preganglionic, and in pure autonomic failure (PAF), where it is postganglionic." | 5.12 | Hemodynamic effects of clonidine in two contrasting models of autonomic failure: multiple system atrophy and pure autonomic failure. ( Asahina, M; Mathias, CJ; Watson, L; Young, TM, 2006) |
| "The clonidine-growth hormone test (CGHT) has been proposed as a means of differentiating multiple system atrophy (MSA) from idiopathic Parkinson's disease (PD)." | 3.71 | Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography. ( Kim, BJ; Lee, EA; Lee, WY, 2002) |
| "Clonidine has been proposed to differentiate multiple system atrophy (MSA) from idiopathic Parkinson's disease (IPD), as it does not increase growth hormone (GH) release in MSA." | 3.71 | Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia. ( Barone, P; Colao, AM; De Michele, G; Faggiano, A; Filla, A; Pellecchia, MT; Pivonello, R; Salvatore, E, 2001) |
| "Clonidine, a centrally active alpha 2-adrenoreceptor agonist used to lower blood pressure, has been proposed to differentiate central from peripheral autonomic deficits and multiple system atrophy (MSA) from untreated idiopathic Parkinson's disease (IPD)." | 3.70 | Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease? ( Echaniz-Laguna, A; Guiraud-Chaumeil, C; Tranchant, C; Warter, JM, 2000) |
| "Idiopathic Parkinson's disease (IPD) is a common neurodegenerative disorder whose differential diagnosis from other forms of atypical parkinsonism, for instance multiple system atrophy (MSA) or progressive supranuclear palsy, may be difficult, especially in the early stages." | 2.43 | Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease. ( Barone, P; Colao, A; Pellecchia, MT; Pivonello, R, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnard, C | 1 |
| Wirth, T | 1 |
| Gebus, O | 1 |
| Fahrer, P | 1 |
| Montaut, S | 1 |
| Robelin, L | 1 |
| Tuzin, N | 1 |
| Tranchant, C | 3 |
| Anheim, M | 2 |
| Alves Do Rego, C | 1 |
| Namer, IJ | 1 |
| Marcel, C | 1 |
| Lefebvre, F | 1 |
| Lagha-Boukbiza, O | 1 |
| Renaud, M | 1 |
| Jordan, J | 1 |
| Shibao, C | 1 |
| Biaggioni, I | 1 |
| Zhang, K | 1 |
| Zeng, Y | 1 |
| Song, C | 1 |
| Fu, Y | 1 |
| Wan, Q | 1 |
| Lee, EA | 1 |
| Kim, BJ | 1 |
| Lee, WY | 1 |
| Pellecchia, MT | 3 |
| Pivonello, R | 3 |
| Salvatore, E | 2 |
| Faggiano, A | 2 |
| Barone, P | 3 |
| De Michele, G | 2 |
| Lombardi, G | 1 |
| Colao, A | 2 |
| Filla, A | 2 |
| Young, TM | 1 |
| Asahina, M | 1 |
| Watson, L | 3 |
| Mathias, CJ | 3 |
| Hiner, BC | 1 |
| Deguchi, K | 1 |
| Ikeda, K | 1 |
| Shimamura, M | 1 |
| Urai, Y | 1 |
| Tsukaguchi, M | 1 |
| Touge, T | 1 |
| Takeuchi, H | 1 |
| Sasaki, I | 1 |
| Kuriyama, S | 1 |
| Kimber, J | 2 |
| Guiraud-Chaumeil, C | 1 |
| Echaniz-Laguna, A | 1 |
| Warter, JM | 1 |
| Colao, AM | 1 |
| Muthane, U | 1 |
1 review available for clonidine and Multiple System Atrophy Syndrome
| Article | Year |
|---|---|
Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease.
Topics: Adrenergic alpha-Agonists; Arginine; Clonidine; Diagnosis, Differential; Growth Hormone; Humans; Mul | 2006 |
2 trials available for clonidine and Multiple System Atrophy Syndrome
| Article | Year |
|---|---|
The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathic Parkinson's disease.
Topics: Aged; Arginine; Clonidine; Diagnosis, Differential; Drug Combinations; Female; Human Growth Hormone; | 2010 |
Hemodynamic effects of clonidine in two contrasting models of autonomic failure: multiple system atrophy and pure autonomic failure.
Topics: Adrenergic alpha-Agonists; Autonomic Nervous System Diseases; Blood Pressure; Case-Control Studies; | 2006 |
11 other studies available for clonidine and Multiple System Atrophy Syndrome
| Article | Year |
|---|---|
Clonidine GH stimulation test to differentiate MSA from idiopathic late onset cerebellar ataxia: a prospective, controlled study.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Clonidine; Diagnosis, Differential; Early Diagnosis; Fem | 2020 |
Prospective study of relevance of
Topics: 3-Iodobenzylguanidine; Biomarkers; Clonidine; Diagnosis, Differential; Female; Follow-Up Studies; He | 2018 |
Multiple system atrophy: using clinical pharmacology to reveal pathophysiology.
Topics: Atomoxetine Hydrochloride; Autonomic Nervous System; Clonidine; Diagnosis, Differential; Drug Therap | 2015 |
Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography.
Topics: Aged; Anal Canal; Clonidine; Diagnosis, Differential; Electromyography; Female; Human Growth Hormone | 2002 |
Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
Topics: Arginine; Case-Control Studies; Clonidine; Diagnosis, Differential; Female; Growth Hormone; Growth H | 2005 |
Differential diagnosis of Parkinson's disease: a new blood test?
Topics: Adrenergic alpha-Agonists; Arginine; Clonidine; Diagnosis, Differential; Growth Hormone; Humans; Mul | 2006 |
Assessment of autonomic dysfunction of multiple system atrophy with laryngeal abductor paralysis as an early manifestation.
Topics: Aged; Arginine Vasopressin; Cerebellar Ataxia; Clonidine; Diagnosis, Differential; Female; Human Gro | 2007 |
Abnormal suppression of arginine-vasopressin by clonidine in multiple system atrophy.
Topics: Adrenergic alpha-Agonists; Aged; Arginine Vasopressin; Blood Pressure; Catecholamines; Clonidine; Di | 1999 |
Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?
Topics: Aged; Aged, 80 and over; Clonidine; Diagnosis, Differential; Female; Growth Hormone; Humans; Male; M | 2000 |
Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia.
Topics: Adrenergic alpha-Agonists; Arginine; Clonidine; Diagnosis, Differential; Drug Administration Schedul | 2001 |
Is clonidine-growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?
Topics: Clonidine; Diagnosis, Differential; Growth Hormone; Humans; Multiple System Atrophy; Parkinson Disea | 2002 |